162 related articles for article (PubMed ID: 6237715)
1. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain.
Brooksbank BW; Balazs R
Brain Res; 1984 Sep; 318(1):37-44. PubMed ID: 6237715
[TBL] [Abstract][Full Text] [Related]
2. Superoxide dismutase and lipoperoxidation in Down's syndrome fetal brain.
Brooksbank BW; Balázs R
Lancet; 1983 Apr; 1(8329):881-2. PubMed ID: 6132215
[No Abstract] [Full Text] [Related]
3. Altered composition of polyunsaturated fatty acyl groups in phosphoglycerides of Down's syndrome fetal brain.
Brooksbank BW; Martinez M; Balazs R
J Neurochem; 1985 Mar; 44(3):869-74. PubMed ID: 3156210
[TBL] [Abstract][Full Text] [Related]
4. Lipid peroxidation and superoxide dismutase-1 and glutathione peroxidase activities in trisomy 16 fetal mice and human trisomy 21 fibroblasts.
Annerén KG; Epstein CJ
Pediatr Res; 1987 Jan; 21(1):88-92. PubMed ID: 2948148
[TBL] [Abstract][Full Text] [Related]
5. Regular exercise did not modify significantly superoxide dismutase activity in adolescents with Down's syndrome.
Ordoñez FJ; Rosety M; Rosety-Rodriguez M
Br J Sports Med; 2006 Aug; 40(8):717-8. PubMed ID: 16864566
[TBL] [Abstract][Full Text] [Related]
6. Lipid peroxides in blood plasma and enzymatic antioxidative defence of erythrocytes in Down's syndrome.
Kedziora J; Bartosz G; Gromadzińska J; Skłodowska M; Wesowicz W; Scianowski J
Clin Chim Acta; 1986 Feb; 154(3):191-4. PubMed ID: 2937579
[TBL] [Abstract][Full Text] [Related]
7. Cu/Zn superoxide dismutase quantification from fetal erythrocytes--an efficient confirmatory test for Down's syndrome after maternal serum screening and sonographic investigations.
Porstmann T; Wietschke R; Cobet G; Stamminger G; Bollmann R; Rogalski V; Pas P
Prenat Diagn; 1991 May; 11(5):295-303. PubMed ID: 1716762
[TBL] [Abstract][Full Text] [Related]
8. Glutathione peroxidase activity, lipid peroxides and selenium status in blood in patients with Down's syndrome.
Gromadzińska J; Wasowicz W; Skłodowska M; Strózyński H
J Clin Chem Clin Biochem; 1988 May; 26(5):255-8. PubMed ID: 2969937
[TBL] [Abstract][Full Text] [Related]
9. Early glycoxidation damage in brains from Down's syndrome.
Odetti P; Angelini G; Dapino D; Zaccheo D; Garibaldi S; Dagna-Bricarelli F; Piombo G; Perry G; Smith M; Traverso N; Tabaton M
Biochem Biophys Res Commun; 1998 Feb; 243(3):849-51. PubMed ID: 9501012
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of oxygen derivatives in down's syndrome.
Sinet PM
Ann N Y Acad Sci; 1982; 396():83-94. PubMed ID: 6217779
[No Abstract] [Full Text] [Related]
11. The role of alterations in free radical metabolism in mediating cognitive impairments in Down's syndrome.
Brugge KL; Nichols S; Delis D; Saitoh T; Truaner D
EXS; 1992; 62():190-8. PubMed ID: 1450586
[TBL] [Abstract][Full Text] [Related]
12. Sudden infant death syndrome: oxidative stress.
Reid GM; Tervit H
Med Hypotheses; 1999 Jun; 52(6):577-80. PubMed ID: 10459841
[TBL] [Abstract][Full Text] [Related]
13. Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease.
Hayn M; Kremser K; Singewald N; Cairns N; Nemethova M; Lubec B; Lubec G
Life Sci; 1996; 59(7):537-44. PubMed ID: 8761342
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical quantification of Cu/Zn superoxide dismutase in prenatal diagnosis of Down's syndrome.
Porstmann T; Wietschke R; Cobet G; Lorenz K; Grunow R; Jahn S; Bollmann R; Stamminger G; von Baehr R
Hum Genet; 1990 Aug; 85(3):362-6. PubMed ID: 2144256
[TBL] [Abstract][Full Text] [Related]
15. Increased superoxide dismutase and Down's syndrome.
Turrens JF
Med Hypotheses; 2001 Jun; 56(6):617-9. PubMed ID: 11399108
[TBL] [Abstract][Full Text] [Related]
16. Expression of transfected human CuZn superoxide dismutase gene in mouse L cells and NS20Y neuroblastoma cells induces enhancement of glutathione peroxidase activity.
Ceballos I; Delabar JM; Nicole A; Lynch RE; Hallewell RA; Kamoun P; Sinet PM
Biochim Biophys Acta; 1988 Jan; 949(1):58-64. PubMed ID: 3334851
[TBL] [Abstract][Full Text] [Related]
17. Cell damage by excess CuZnSOD and Down's syndrome.
Groner Y; Elroy-Stein O; Avraham KB; Schickler M; Knobler H; Minc-Golomb D; Bar-Peled O; Yarom R; Rotshenker S
Biomed Pharmacother; 1994; 48(5-6):231-40. PubMed ID: 7999984
[TBL] [Abstract][Full Text] [Related]
18. Down's syndrome astrocytes have greater antioxidant capacity than euploid astrocytes.
Sebastià J; Cristòfol R; Pertusa M; Vílchez D; Torán N; Barambio S; Rodríguez-Farré E; Sanfeliu C
Eur J Neurosci; 2004 Nov; 20(9):2355-66. PubMed ID: 15525277
[TBL] [Abstract][Full Text] [Related]
19. Neurochemical approaches to the pathogenesis of Down's syndrome.
Balazs R; Brooksbank BW
J Ment Defic Res; 1985 Mar; 29 ( Pt 1)():1-14. PubMed ID: 3159898
[No Abstract] [Full Text] [Related]
20. Evaluation of superoxide dismutase and glutathione peroxidase enzymes and their cofactors in Egyptian children with Down's syndrome.
Meguid NA; Kholoussi NM; Afifi HH
Biol Trace Elem Res; 2001 Jul; 81(1):21-8. PubMed ID: 11508329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
